Skip to main content

Stem Cell Therapy for Fanconi Anemia

  • Conference paper
  • First Online:
Stem Cells: Biology and Engineering

Part of the book series: Advances in Experimental Medicine and Biology ((ICRRM,volume 1083))

Abstract

Stem cell therapy is the administration of stem cells to a patient to treat or prevent a disease. Since stem cells possess the long-term self-renewal capacity and provide daughter cells that differentiate into the specialized cells of each tissue, stem cell therapy will theoretically improve the disease condition for the lifetime of the patient. As the most widely used stem cell therapy, bone marrow transplantation is the treatment of choice for many kinds of blood disorders, including anemias, leukemias, lymphomas, and rare immunodeficiency diseases. For the fatal genetic blood disorder Fanconi anemia, allogeneic bone marrow transplantation has remained the only curative treatment. But the recent advances in stem cell and gene therapy fields may provide promising opportunities for an alternative or even better management of Fanconi anemia. Many of these new ideas and opportunities are also useful for treating other blood diseases that affect hematopoietic stem cells, such as sickle cell anemia, severe combined immunodeficiencies, and beta-thalassemias. In this chapter, these advances along with their challenges and limitations will be thoroughly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

AAV:

Adeno-associated virus

FA:

Fanconi anemia

GVHD:

Graft-versus-host disease

HLA:

Human leukocyte antigens

HSCT:

Hematopoietic stem cell transplantation

HSPC:

Hematopoietic stem and progenitor cell

iPS:

Induced pluripotent stem cell

References

  • Auerbach, A. D. (2009). Fanconi anemia and its diagnosis. Mutation Research, 668(1–2), 4–10. doi:10.1016/j.mrfmmm.2009.01.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Battaile, K. P., Bateman, R. L., Mortimer, D., Mulcahy, J., Rathbun, R. K., Bagby, G., Fleming, W. H., & Grompe, M. (1999). In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood, 94(6), 2151–2158.

    CAS  PubMed  Google Scholar 

  • Becker, P. S., Taylor, J. A., Trobridge, G. D., Zhao, X., Beard, B. C., Chien, S., Adair, J., Kohn, D. B., Wagner, J. E., Shimamura, A., & Kiem, H. P. (2010). Preclinical correction of human Fanconi anemia complementation group a bone marrow cells using a safety-modified lentiviral vector. Gene Therapy, 17(10), 1244–1252. doi:10.1038/gt.2010.62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., Schultz, P. G., & Cooke, M. P. (2010). Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science, 329(5997), 1345–1348. doi:10.1126/science.1191536.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bryder, D., Rossi, D. J., & Weissman, I. L. (2006). Hematopoietic stem cells: The paradigmatic tissue-specific stem cell. The American Journal of Pathology, 169(2), 338–346. doi:10.2353/ajpath.2006.060312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cavazzana, M. (2014). Hematopoietic stem cell gene therapy: Progress on the clinical front. Human Gene Therapy, 25(3), 165–170. doi:10.1089/hum.2014.2504.

    Article  CAS  PubMed  Google Scholar 

  • Ceccaldi, R., Briot, D., Larghero, J., Vasquez, N., Dubois d’Enghien, C., Chamousset, D., Noguera, M. E., Waisfisz, Q., Hermine, O., Pondarre, C., Leblanc, T., Gluckman, E., Joenje, H., Stoppa-Lyonnet, D., Socie, G., & Soulier, J. (2011). Spontaneous abrogation of the G(2)DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. The Journal of Clinical Investigation, 121(1), 184–194. doi:10.1172/JCI43836.

    Article  CAS  PubMed  Google Scholar 

  • Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., Pla, M., Vasquez, N., Zhang, Q. S., Pondarre, C., Peffault de Latour, R., Gluckman, E., Cavazzana-Calvo, M., Leblanc, T., Larghero, J., Grompe, M., Socie, G., D’Andrea, A. D., & Soulier, J. (2012). Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell, 11(1), 36–49. doi:10.1016/j.stem.2012.05.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Daniel, M. G., Pereira, C. F., Lemischka, I. R., & Moore, K. A. (2016). Making a hematopoietic stem cell. Trends in Cell Biology, 26(3), 202–214. doi:10.1016/j.tcb.2015.10.002.

    Article  PubMed  Google Scholar 

  • Demarosi, F., Lodi, G., Carrassi, A., Soligo, D., & Sardella, A. (2005). Oral malignancies following HSCT: Graft versus host disease and other risk factors. Oral Oncology, 41(9), 865–877. doi:10.1016/j.oraloncology.2005.02.001.

    Article  PubMed  Google Scholar 

  • Dokal, I. (2003). Inherited aplastic anaemia. The Hematology Journal: The Official Journal of the European Haematology Association/EHA, 4(1), 3–9. doi:10.1038/sj.thj.6200215.

    Article  CAS  Google Scholar 

  • Dong, H., Nebert, D. W., Bruford, E. A., Thompson, D. C., Joenje, H., & Vasiliou, V. (2015). Update of the human and mouse Fanconi anemia genes. Human Genomics, 9(1), 32. doi:10.1186/s40246-015-0054-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fu, K. L., Foe, J. R., Joenje, H., Rao, K. W., Liu, J. M., & Walsh, C. E. (1997). Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer. Blood, 90(9), 3296–3303.

    CAS  PubMed  Google Scholar 

  • Galimi, F., Noll, M., Kanazawa, Y., Lax, T., Chen, C., Grompe, M., & Verma, I. M. (2002). Gene therapy of Fanconi anemia: Preclinical efficacy using lentiviral vectors. Blood, 100(8), 2732–2736. doi:10.1182/blood-2002-04-1245.

    Article  CAS  PubMed  Google Scholar 

  • Gaspar, H. B., Cooray, S., Gilmour, K. C., Parsley, K. L., Zhang, F., Adams, S., Bjorkegren, E., Bayford, J., Brown, L., Davies, E. G., Veys, P., Fairbanks, L., Bordon, V., Petropoulou, T., Kinnon, C., & Thrasher, A. J. (2011). Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Science Translational Medicine, 3(97), 97ra80. doi:10.1126/scitranslmed.3002716.

    Article  CAS  PubMed  Google Scholar 

  • Gluckman, E., & Wagner, J. E. (2008). Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplantation, 41(2), 127–132. doi:10.1038/sj.bmt.1705960.

    Article  CAS  PubMed  Google Scholar 

  • Gluckman, E., Rocha, V., Ionescu, I., Bierings, M., Harris, R. E., Wagner, J., Kurtzberg, J., Champagne, M. A., Bonfim, C., Bittencourt, M., Darbyshire, P., Fernandez, M. N., Locatelli, F., & Pasquini, R. (2007). Results of unrelated cord blood transplant in Fanconi anemia patients: Risk factor analysis for engraftment and survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 13(9), 1073–1082. doi:10.1016/j.bbmt.2007.05.015.

    Article  Google Scholar 

  • Gross, M., Hanenberg, H., Lobitz, S., Friedl, R., Herterich, S., Dietrich, R., Gruhn, B., Schindler, D., & Hoehn, H. (2002). Reverse mosaicism in Fanconi anemia: Natural gene therapy via molecular self-correction. Cytogenet Genome Research, 98(2–3), 126–135. doi:69805.

    Article  CAS  Google Scholar 

  • Gush, K. A., Fu, K. L., Grompe, M., & Walsh, C. E. (2000). Phenotypic correction of Fanconi anemia group C knockout mice. Blood, 95(2), 700–704.

    CAS  PubMed  Google Scholar 

  • Habi, O., Delisle, M. C., Messier, N., & Carreau, M. (2005). Lack of self-renewal capacity in Fancc−/− stem cells after ex vivo expansion. Stem Cells, 23(8), 1135–1141. doi:10.1634/stemcells.2004-0356.

    Article  PubMed  Google Scholar 

  • Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G. P., Berry, C. C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B. H., Leiva, L., Sorensen, R., Debre, M., Casanova, J. L., Blanche, S., Durandy, A., Bushman, F. D., Fischer, A., & Cavazzana-Calvo, M. (2010). Efficacy of gene therapy for X-linked severe combined immunodeficiency. The New England Journal of Medicine, 363(4), 355–364. doi:10.1056/NEJMoa1000164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L. C., Townes, T. M., & Jaenisch, R. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318(5858), 1920–1923. doi:10.1126/science.1152092.

    Article  CAS  PubMed  Google Scholar 

  • Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R. C., Katibah, G. E., Amora, R., Boydston, E. A., Zeitler, B., Meng, X., Miller, J. C., Zhang, L., Rebar, E. J., Gregory, P. D., Urnov, F. D., & Jaenisch, R. (2009). Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnology, 27(9), 851–857. doi:10.1038/nbt.1562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., Zeitler, B., Cherone, J. M., Meng, X., Hinkley, S. J., Rebar, E. J., Gregory, P. D., Urnov, F. D., & Jaenisch, R. (2011). Genetic engineering of human pluripotent cells using TALE nucleases. Nature Biotechnology, 29(8), 731–734. doi:10.1038/nbt.1927.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157(6), 1262–1278. doi:10.1016/j.cell.2014.05.010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kelly, P. F., Radtke, S., von Kalle, C., Balcik, B., Bohn, K., Mueller, R., Schuesler, T., Haren, M., Reeves, L., Cancelas, J. A., Leemhuis, T., Harris, R., Auerbach, A. D., Smith, F. O., Davies, S. M., & Williams, D. A. (2007). Stem cell collection and gene transfer in Fanconi anemia. Molecular Therapy, 15(1), 211–219. doi:10.1038/sj.mt.6300033.

    Article  CAS  PubMed  Google Scholar 

  • Kiem, H. P., Jerome, K. R., Deeks, S. G., & McCune, J. M. (2012). Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell, 10(2), 137–147. doi:10.1016/j.stem.2011.12.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim, H., & D’Andrea, A. D. (2012). Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes & Development, 26(13), 1393–1408. doi:10.1101/gad.195248.112.

    Article  CAS  Google Scholar 

  • Kruse, A. L., Zwahlen, R. A., & Gratz, K. W. (2009). New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years. Head & Neck Oncology, 1, 31. doi:10.1186/1758-3284-1-31.

    Article  Google Scholar 

  • Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003). A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood, 101(4), 1249–1256. doi:10.1182/blood-2002-07-2170.

    Article  CAS  PubMed  Google Scholar 

  • Lemoli, R. M., & D’Addio, A. (2008). Hematopoietic stem cell mobilization. Haematologica, 93(3), 321–324. doi:10.3324/haematol.12616.

    Article  PubMed  Google Scholar 

  • Liu, J. M., Young, N. S., Walsh, C. E., Cottler-Fox, M., Carter, C., Dunbar, C., Barrett, A. J., & Emmons, R. (1997). Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients. Human Gene Therapy, 8(14), 1715–1730. doi:10.1089/hum.1997.8.14-1715.

    Article  CAS  PubMed  Google Scholar 

  • Liu, J. M., Kim, S., Read, E. J., Futaki, M., Dokal, I., Carter, C. S., Leitman, S. F., Pensiero, M., Young, N. S., & Walsh, C. E. (1999). Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Human Gene Therapy, 10(14), 2337–2346. doi:10.1089/10430349950016988.

    Article  CAS  PubMed  Google Scholar 

  • Macmillan, M. L., Blazar, B. R., DeFor, T. E., & Wagner, J. E. (2009). Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplantation, 43(6), 447–454. doi:10.1038/bmt.2008.348.

    Article  CAS  PubMed  Google Scholar 

  • MacMillan, M. L., Hughes, M. R., Agarwal, S., & Daley, G. Q. (2011). Cellular therapy for fanconi anemia: The past, present, and future. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation, 17(1 Suppl), S109–S114. doi:10.1016/j.bbmt.2010.11.027.

    Article  Google Scholar 

  • MacMillan, M. L., DeFor, T. E., Young, J. A., Dusenbery, K. E., Blazar, B. R., Slungaard, A., Zierhut, H., Weisdorf, D. J., & Wagner, J. E. (2015). Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood, 125(24), 3798–3804. doi:10.1182/blood-2015-02-626002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mankad, A., Taniguchi, T., Cox, B., Akkari, Y., Rathbun, R. K., Lucas, L., Bagby, G., Olson, S., D’Andrea, A., & Grompe, M. (2006). Natural gene therapy in monozygotic twins with Fanconi anemia. Blood, 107(8), 3084–3090. doi:10.1182/blood-2005-07-2638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Molina-Estevez, F. J., Nowrouzi, A., Lozano, M. L., Galy, A., Charrier, S., von Kalle, C., Guenechea, G., Bueren, J. A., & Schmidt, M. (2015). Lentiviral-mediated Gene therapy in Fanconi anemia-A mice reveals long-term engraftment and continuous turnover of corrected HSCs. Current Gene Therapy, 15(6), 550–562.

    Article  CAS  PubMed  Google Scholar 

  • Monti, D., Macchioni, S., Guido, M., Pagano, G., Zatterale, A., Calzone, R., Cossarizza, A., Straface, E., Malorni, W., & Franceschi, C. (1997). Resistance to apoptosis in Fanconi’s anaemia. An ex vivo study in peripheral blood mononuclear cells. FEBS Letters, 409(3), 365–369.

    Article  CAS  PubMed  Google Scholar 

  • Muller, L. U., Milsom, M. D., Harris, C. E., Vyas, R., Brumme, K. M., Parmar, K., Moreau, L. A., Schambach, A., Park, I. H., London, W. B., Strait, K., Schlaeger, T., Devine, A. L., Grassman, E., D’Andrea, A., Daley, G. Q., & Williams, D. A. (2012). Overcoming reprogramming resistance of Fanconi anemia cells. Blood, 119(23), 5449–5457. doi:10.1182/blood-2012-02-408674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Osborn, M. J., Gabriel, R., Webber, B. R., DeFeo, A. P., McElroy, A. N., Jarjour, J., Starker, C. G., Wagner, J. E., Joung, J. K., Voytas, D. F., von Kalle, C., Schmidt, M., Blazar, B. R., & Tolar, J. (2015). Fanconi anemia gene editing by the CRISPR/Cas9 system. Human Gene Therapy, 26(2), 114–126. doi:10.1089/hum.2014.111.

    Article  CAS  PubMed  Google Scholar 

  • Raya, A., Rodriguez-Piza, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castella, M., Rio, P., Sleep, E., Gonzalez, F., Tiscornia, G., Garreta, E., Aasen, T., Veiga, A., Verma, I. M., Surralles, J., Bueren, J., & Izpisua Belmonte, J. C. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460(7251), 53–59. doi:10.1038/nature08129.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinton, D. A., & Daley, G. Q. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature, 481(7381), 295–305. doi:10.1038/nature10761.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosemann, A. (2014). Why regenerative stem cell medicine progresses slower than expected. Journal of Cellular Biochemistry, 115(12), 2073–2076. doi:10.1002/jcb.24894.

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg, P. S., Alter, B. P., & Ebell, W. (2008). Cancer risks in Fanconi anemia: Findings from the German Fanconi anemia registry. Haematologica, 93(4), 511–517. doi:10.3324/haematol.12234.

    Article  PubMed  Google Scholar 

  • Seita, J., & Weissman, I. L. (2010). Hematopoietic stem cell: Self-renewal versus differentiation. Wiley Interdisciplinary Reviews Systems Biology and Medicine, 2(6), 640–653. doi:10.1002/wsbm.86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shimamura, A., & Alter, B. P. (2010). Pathophysiology and management of inherited bone marrow failure syndromes. Blood Reviews, 24(3), 101–122. doi:10.1016/j.blre.2010.03.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Si, Y., Pulliam, A. C., Linka, Y., Ciccone, S., Leurs, C., Yuan, J., Eckermann, O., Fruehauf, S., Mooney, S., Hanenberg, H., & Clapp, D. W. (2008). Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc−/− stem cells. Blood, 112(12), 4458–4465. doi:10.1182/blood-2007-07-102947.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singhal, S., Powles, R., Kulkarni, S., Treleaven, J., Sirohi, B., Millar, B., Shepherd, V., Saso, R., Rowland, A., Long, S., Cabral, S., Horton, C., & Mehta, J. (2000). Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Bone Marrow Transplantation, 25(5), 501–505. doi:10.1038/sj.bmt.1702173.

    Article  CAS  PubMed  Google Scholar 

  • Socie, G., Devergie, A., Girinski, T., Piel, G., Ribaud, P., Esperou, H., Parquet, N., Maarek, O., Noguera, M. H., Richard, P., Brison, O., & Gluckman, E. (1998). Transplantation for Fanconi’s anaemia: Long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. British Journal of Haematology, 103(1), 249–255.

    Article  CAS  PubMed  Google Scholar 

  • Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988). Purification and characterization of mouse hematopoietic stem cells. Science, 241(4861), 58–62.

    Article  CAS  PubMed  Google Scholar 

  • Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676. doi:10.1016/j.cell.2006.07.024.

    Article  CAS  PubMed  Google Scholar 

  • Tolar, J., Adair, J. E., Antoniou, M., Bartholomae, C. C., Becker, P. S., Blazar, B. R., Bueren, J., Carroll, T., Cavazzana-Calvo, M., Clapp, D. W., Dalgleish, R., Galy, A., Gaspar, H. B., Hanenberg, H., Von Kalle, C., Kiem, H. P., Lindeman, D., Naldini, L., Navarro, S., Renella, R., Rio, P., Sevilla, J., Schmidt, M., Verhoeyen, E., Wagner, J. E., Williams, D. A., & Thrasher, A. J. (2011). Stem cell gene therapy for Fanconi anemia: Report from the 1st international Fanconi anemia gene therapy working group meeting. Molecular Therapy, 19(7), 1193–1198. doi:10.1038/mt.2011.78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tolar, J., Becker, P. S., Clapp, D. W., Hanenberg, H., de Heredia, C. D., Kiem, H. P., Navarro, S., Qasba, P., Rio, P., Schmidt, M., Sevilla, J., Verhoeyen, E., Thrasher, A. J., & Bueren, J. (2012). Gene therapy for Fanconi anemia: One step closer to the clinic. Human Gene Therapy, 23(2), 141–144. doi:10.1089/hum.2011.237.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wagner, J. E., & Gluckman, E. (2010). Umbilical cord blood transplantation: The first 20 years. Seminars in Hematology, 47(1), 3–12. doi:10.1053/j.seminhematol.2009.10.011.

    Article  PubMed  Google Scholar 

  • Waisfisz, Q., Morgan, N. V., Savino, M., de Winter, J. P., van Berkel, C. G., Hoatlin, M. E., Ianzano, L., Gibson, R. A., Arwert, F., Savoia, A., Mathew, C. G., Pronk, J. C., & Joenje, H. (1999). Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genetics, 22(4), 379–383. doi:10.1038/11956.

    Article  CAS  PubMed  Google Scholar 

  • Yin, H., Song, C. Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., Gupta, A., Bolukbasi, M. F., Walsh, S., Bogorad, R. L., Gao, G., Weng, Z., Dong, Y., Koteliansky, V., Wolfe, S. A., Langer, R., Xue, W., & Anderson, D. G. (2016). Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nature Biotechnology. doi:10.1038/nbt.3471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang, Q. S., Benedetti, E., Deater, M., Schubert, K., Major, A., Pelz, C., Impey, S., Marquez-Loza, L., Rathbun, R. K., Kato, S., Bagby, G. C., & Grompe, M. (2015). Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling. Stem Cell Reports, 4(1), 90–102. doi:10.1016/j.stemcr.2014.10.014.

    Article  CAS  PubMed  Google Scholar 

  • Zou, J., Maeder, M. L., Mali, P., Pruett-Miller, S. M., Thibodeau-Beganny, S., Chou, B. K., Chen, G., Ye, Z., Park, I. H., Daley, G. Q., Porteus, M. H., Joung, J. K., & Cheng, L. (2009). Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell, 5(1), 97–110. doi:10.1016/j.stem.2009.05.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing-Shuo Zhang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this paper

Cite this paper

Zhang, QS. (2017). Stem Cell Therapy for Fanconi Anemia. In: Van Pham, P. (eds) Stem Cells: Biology and Engineering. Advances in Experimental Medicine and Biology(), vol 1083. Springer, Cham. https://doi.org/10.1007/5584_2017_67

Download citation

Publish with us

Policies and ethics